Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration | Zendy

Malik Salman Haider | Zendy; Arun Kumar Mahato | Zendy; Анастасия Котлярова | Zendy; Stefan Forster | Zendy; Bettina Böttcher | Zendy; Philipp Stahlhut | Zendy; Yulia Sidorova | Zendy; Robert Luxenhofer | Zendy

Open Access

Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration

Author(s) -

Malik Salman Haider,

Arun Kumar Mahato,

Анастасия Котлярова,

Stefan Forster,

Bettina Böttcher,

Philipp Stahlhut,

Yulia Sidorova,

Robert Luxenhofer

Publication year - 2022

Publication title -

biomacromolecules

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.689

H-Index - 220

eISSN - 1526-4602

pISSN - 1525-7797

DOI - 10.1021/acs.biomac.2c00761

Subject(s) - dynamic light scattering , differential scanning calorimetry , bioavailability , chemistry , biophysics , in vitro , solubility , aqueous solution , absorption (acoustics) , neurodegeneration , materials science , nuclear chemistry , pharmacology , biochemistry , nanotechnology , nanoparticle , organic chemistry , medicine , biology , disease , physics , pathology , thermodynamics , composite material

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research